Back

Telemedicine for oral anticoagulation management: a systematic review and meta-analysis of effectiveness and safety

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: The digital cardiologist: telemedicine and cardiovascular disease management Remote Patient Monitoring and Telehealth ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Assistant Professor Milena Marcolino

Federal University of Minas Gerais, Belo Horizonte (Brazil)

5 More presentations in this session

Presentation thumbnail
Effective blood pressure reduction by HartWacht telemonitoring after 12-months follow-up
Mr Y. Schut (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Factors associated with the levels of eHealth literacy skills among patients in cardiovascular care: secondary analysis of data from users of a hypertension management app
Professor S. Spethmann (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Non-invasive telemonitoring in chronic heart failure: a systematic review and meta-analysis of randomised controlled trials
Doctor H. Amorim Parente (Rio de Janeiro, BR)
Abstract Slides Video
Presentation thumbnail
Feasibility of a randomised controlled trial of the aktivplan digital intervention for regular physical activity following phase II rehabilitation: the ACTIVE-CaRe Pilot study
Mr D. Leysen (Salzburg, AT)
Abstract Slides Video
Presentation thumbnail
Early results from a pilot RCT of a HeartLogic-driven mHealth pathway (NOTIFY-HF) for early heart failure intervention
Doctor J. Assad (Liverpool, AU)
Abstract Slides Video

Access the full session

Session thumbnail
The digital cardiologist: telemedicine and cardiovascular disease management

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Anticoagulation strategy of choice for atrial fibrillation ablation - a network meta-analysis of complication rates
thumbnail
Congress Presentation
Risk and benefits of baseline antiplatelet therapy in 58,598 patients with atrial fibrillation randomized to NOACs vs warfarin
thumbnail
Congress Presentation
Association between warfarin and direct oral anticoagulants users and risk of mortality: cohort studies in England and Hong Kong

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources